ARAlexander J. Rago

Alexander J. Rago

*This is an algorithmically generated author record based on publicly available information.

Alexander J. Rago has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Catalytic Asymmetric Metallocyclopropanation Reactions Using Chloroform as a Carbyne Equivalent

    by Raymond J. Martinez, Divya Garg, Luke R. Harrison, Alexander J. Rago, Jonathon M. Young, Martin Garcia Chavez, Eric A. Voight, Christopher Uyeda

    Stereochemically complex, sp3-rich rings have attracted significant interest in drug discovery because of their ability to mitigate the physicochemical liabilities associated with flat aromatic rings. Cyclopropanes are attractive targets in this regard because they have unique three-dimensional structures and are resistant to metabolism. Numerous catalytic enantioselective alkene cyclopropanation reactions have been developed using carbene precursors. However, most of these methods use energetic reagents and are restricted to specific classes of resonance-stabilized carbenes. Here, we report a catalytic asymmetric cyclopropanation reaction using chloroform as a methylidyne equivalent and Zn as a stoichiometric reductant. The products are metallocyclopropanes that can be further functionalized in a telescoped process to yield halo-, aryl-, allyl-, alkynyl-, vinyl-, and other substituted cyclopropanes in highly enantioenriched form. A notable feature of the reaction is the high degree of cis diastereoselectivity, which is controlled by the large N-aryl substituent of the ligand. Application in the parallel synthesis of enantioenriched 1,2-diarylcyclopropanes bearing pharmaceutically relevant heterocycles is demonstrated.


  • Open Access

    A machine learning-based workflow for transaminase selection

    by Alexander J. Rago, Priyanka Raghavan, Lisandra Santiago-Capeles, Ruijie Zhang, Ying Wang, Connor W. Coley

    Predictive ML models enable the rank-ordering of transaminase enzymes for a given substrate based on their predicted reactivities, thus expediting enzyme selection for chiral amine synthesis in medicinal chemistry research.

  • Mining Medicinally Relevant Bioreduction Substrates Inspired by Ligand-Based Drug Design

    by Alexander J. Rago, Ioanna Zoi, Jackson A. Gartman, Kelly A. McDaniel, Navendu Jana, Dachun Liu, Wen-Ju Bai

    Exploring the scope of biocatalytic transformations in the absence of enzyme structures without extensive experimentation is a challenging task. To expand the limited substrate capacity of carrot-mediated bioreduction and hunt for new medicinally relevant ketones with minimum cost of labor and time, we deployed a practical method inspired by ligand-based drug design. Through analyzing collected literature data and building pharmacophore and reactivity prediction models, we screened a self-built virtual library of >8000 ketones bearing the most frequently used N,O,S-heterocycles and functional groups in drug discovery. Representative examples were validated, expanding the bioreduction substrate scope. The public availability of our models alongside the straightforward screening workflow makes it time-, labor-, and cost-saving to evaluate unknown bioreduction substrates for medicinal chemistry applications, especially for a large set of structurally differentiated ketones. Our studies also showcase the novelty of utilizing medicinal chemistry principles to solve a general biocatalysis problem.


  • Open Access

    Incorporating Synthetic Accessibility in Drug Design: Predicting Reaction Yields of Suzuki Cross-Couplings by Leveraging AbbVie’s 15-Year Parallel Library Data Set

    by Priyanka Raghavan, Alexander J. Rago, Pritha Verma, Majdi M. Hassan, Gashaw M. Goshu, Amanda W. Dombrowski, Abhishek Pandey, Connor W. Coley, Ying Wang

    Despite the increased use of computational tools to supplement medicinal chemists' expertise and intuition in drug design, predicting synthetic yields in medicinal chemistry endeavors remains an unsolved challenge. Existing design workflows could profoundly benefit from reaction yield prediction, as precious material waste could be reduced, and a greater number of relevant compounds could be delivered to advance the design, make, test, analyze (DMTA) cycle. In this work, we detail the evaluation of AbbVie's medicinal chemistry library data set to build machine learning models for the prediction of Suzuki coupling reaction yields. The combination of density functional theory (DFT)-derived features and Morgan fingerprints was identified to perform better than one-hot encoded baseline modeling, furnishing encouraging results. Overall, we observe modest generalization to unseen reactant structures within the 15-year retrospective library data set. Additionally, we compare predictions made by the model to those made by expert medicinal chemists, finding that the model can often predict both reaction success and reaction yields with greater accuracy. Finally, we demonstrate the application of this approach to suggest structurally and electronically similar building blocks to replace those predicted or observed to be unsuccessful prior to or after synthesis, respectively. The yield prediction model was used to select similar monomers predicted to have higher yields, resulting in greater synthesis efficiency of relevant drug-like molecules.


  • At the Speed of Light: The Systematic Implementation of Photoredox Cross-Coupling Reactions for Medicinal Chemistry Research

    by Nathan J. Gesmundo, Alexander J. Rago, Jonathon M. Young, Sebastian Keess, Ying Wang

    The adoption of new and emerging techniques in organic synthesis is essential to promote innovation in drug discovery. In this Perspective, we detail the strategy we used for the systematic deployment of photoredox-mediated, metal-catalyzed cross-coupling reactions in AbbVie's medicinal chemistry organization, focusing on topics such as assessment, evaluation, implementation, and accessibility. The comprehensive evaluation of photoredox reaction setups and published methods will be discussed, along with internal efforts to build expertise and photoredox high-throughput experimentation capabilities. We also highlight AbbVie's academic-industry collaborations in this field that have been leveraged to develop new synthetic strategies, along with discussing the internal adoption of photoredox cross-coupling reactions. The work described herein has culminated in robust photocatalysis and cross-coupling capabilities which are viewed as key platforms for medicinal chemistry research at AbbVie.


  • Open Access

    A four-component reaction to access 3,3-disubstituted indolines via the palladium–norbornene-catalyzed ortho amination/ ipso conjunctive coupling

    by Alexander J. Rago, Rong Ye, Xin Liu, Guangbin Dong

    The development of a palladium/norbornene-catalyzed four-component reaction, involving ortho C–H amination/ ipso conjunctive coupling with an alkene and an external nucleophile, is reported.


  • Di(2-picolyl)amines as Modular and Robust Ligands for Nickel-Catalyzed C(sp2)–C(sp3) Cross-Electrophile Coupling

    by Alexander J. Rago, Aristidis Vasilopoulos, Amanda W. Dombrowski, Ying Wang

    Ni-catalyzed aryl-alkyl coupling reactions are reliant on using a limited set of commercially available bidentate nitrogenous ligands to enable the reaction, because noncommercial analogues usually entail challenging syntheses. In this work, di(2-picolyl)amines (DPAs) are explored as an alternative modular ligand class for the nickel-catalyzed aryl-alkyl cross-electrophile coupling. Novel DPA ligands were synthesized directly from inexpensive amine and pyridine building blocks in a single step. This facile synthetic route enabled the parallel synthesis of DPA ligands with varied steric and electronic properties. From this collection of ligands, a few robust ligands for C(sp2)-C(sp3) cross-electrophile coupling were identified and tested in the cross-coupling of a range of diverse molecules, including model examples for late-stage functionalization.


  • Open Access

    Synthesis of indoles, indolines, and carbazoles via palladium-catalyzed C–H activation

    by Alexander J. Rago, Guangbin Dong

    The construction of indole, indoline, and carbazole heterocycles has been of significant interest in the synthetic community over the last century due to their prevalence in natural products and other biologically active compounds. In particular for indoles, many conventional methods developed to date require highly pre-functionalized arene precursors, diminishing their attractiveness as “green” syntheses. Carbon–hydrogen bond activation, on the other hand, presents an elegant solution to this problem and can achieve the construction of indoles and their derivatives from comparatively simpler arene precursors. In this short review, we discuss various approaches for preparing indoles, indolines, and carbazoles via palladium-catalyzed C─H bond activation, highlighting their reaction mechanisms and synthetic applications.


  • Direct β-Alkenylation of Ketones via Pd-Catalyzed Redox Cascade

    by Chengpeng Wang, Alexander J. Rago, Guangbin Dong

    A direct β-alkenylation of simple ketones with alkenyl bromides is reported via a Pd-catalyzed redox cascade strategy. The reaction is redox neutral and directing-group-free, in the absence of strong acids or bases. Both cyclic and linear ketones are suitable substrates, and various alkenyl bromides can be coupled. The resulting β-alkenyl ketones are readily derivatized through diverse alkene functionalization.


  • Platinum‐Catalyzed Desaturation of Lactams, Ketones, and Lactones

    by Ming Chen, Alexander J. Rago, Guangbin Dong

    The development of a general platinum‐catalyzed desaturation of N‐protected lactams, ketones, and lactones to their conjugated α,β‐unsaturated counterparts is reported. The reaction operates under mildly acidic conditions at room temperature or 50 °C. It is scalable and tolerates a wide range of functional groups. The complementary reactivity to the palladium‐catalyzed desaturation is demonstrated in the efficient conversion of iodide, bromide, and sulfur‐containing substrates.